Asset Details
Do you wish to reserve the book?
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
Do you wish to request the book?
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
2012
Overview
Dipeptidyl peptidase 4 (DPP-4) is an enzyme that is produced by endothelial cells in different districts and circulates in plasma. Patients with type 2 diabetes show a reduction in active Glucagon-Like Peptide-1 (GLP-1) that could be due to impairment of secretion or its degradation or both. GLP-1 is rapidly inactivated in vivo, mainly by the DPP-4. Some authors suggest that Metformin has no direct inhibitory effect on DPP-4 activity and that Metformin and the other biguanides enhance GLP-1 secretion; others suggest a possible role of Metformin in the inhibition of the DPP-4 activity. In order to better elucidate the role of insulin sensitizers on the modulation of GLP-1 circulating levels, DPP-4 activity and mRNA expression were measured in cultured human aortic endothelial cells (HAEC) and human microvascular dermal endothelial cells (HMVEC) exposed to high glucose, Metformin and Rosiglitazone. Present data show that hyperglycemia is capable of increasing in a significant manner the DPP-4 activity only in microvascular endothelial cells. Rosiglitazone is able to modulate in a negative manner the expression of DPP-4 but not its activity in macrovascular endothelial cells, while at 24 h of exposure it is able to increase significantly DPP-4 activity but not its expression in microvascular endothelial cells. Metformin at 48 h only in microvascular endothelial cells is able to reduce in a significant manner (
p
= 0.01) the activity of DPP-4 but not its expression. The modulation of DPP-4 is site specific.
Publisher
Springer Milan,Springer Nature B.V
Subject
/ Diabetes
/ Diabetes Mellitus, Type 2 - enzymology
/ Diabetes Mellitus, Type 2 - genetics
/ Diabetes Mellitus, Type 2 - metabolism
/ Dipeptidyl Peptidase 4 - genetics
/ Dipeptidyl Peptidase 4 - metabolism
/ Endothelial Cells - enzymology
/ Endothelial Cells - metabolism
/ Enzymes
/ Gene Expression Regulation, Enzymologic
/ Humans
/ Medicine
